Status:

RECRUITING

EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

Lead Sponsor:

Fondazione Don Carlo Gnocchi Onlus

Conditions:

Cardiovascular Diseases

Diabete Type 2

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Nordic Walking (NW) is a biomechanically correct walking technique that originated in Finland in the 1930s as an off-season training method for cross-country skiers. In the NW, the use of special stic...

Eligibility Criteria

Inclusion

  • \- overweight \[Body Mass Index (BMI) ≥ 27 kg/m2\] or obese (BMI ≥30 kg/m2) adult patients with diabetes mellitus and with a recent cardiovascular event and/or coronary revascularization in the previous three months

Exclusion

  • inability to walk independently and constantly;
  • acute joint or spine pathologies that make movement impossible;
  • the presence of dementia as approved by consultation of the patient's medical record and/or administration of the Montreal Cognitive Assessment (MOCA) test ≤ 15.5 (Nasreddine et al., 2005);
  • chemotherapy 6 months before surgery;
  • advanced renal failure;
  • acute cardiovascular event \< 3 months (unstable angina, AMI with FE \<40%, arrhythmias, valvular disease, intracerebral/subdural haemorrhage, uncontrolled AI);
  • home oxygen therapy and Non-Invasive Ventilation (NIV) \[excluding Continuous Positive Airway Pressure (CPAP)\].

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2026

Estimated Enrollment :

105 Patients enrolled

Trial Details

Trial ID

NCT05987410

Start Date

December 1 2023

End Date

May 31 2026

Last Update

February 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Fondazione Don Carlo Gnocchi

Milan, Italy, 20148